Nevertheless, to efficiently target the TGF-β pathway, it is mandatory to deepen into the molecular mechanisms through which TGF-β promotes tumor progression as well as to identify relevant biomarkers of the TGF-β oncogenic arms. The gene discussed is TGFB1; the disease is neoplasm.